Efficacy and Safety of Esketamine in the Treatment of Patients With Treatment Resistant Major Depression

Update Il y a 4 ans
Reference: EUCTR2011-005992-17

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of the study is to evaluate the efficacy, safety, and tolerability of esketamine in subjects with treatment resistant depression. Efficacy in improving symptoms compared with a placebo will be assessed by the changes from randomisation to end of week 1 in the Montgomery-Åsberg Depression Rating Scale (MADRS) total score.


Inclusion criteria

  • Treatment-resistant Major Depression